Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease

Eur J Nucl Med. 1992;19(1):14-8. doi: 10.1007/BF00178302.

Abstract

The inflammatory activity in 108 bowel segments of 40 patients with suspected or known inflammatory bowel disease was assessed macroscopically by endoscopy, histology and technetium-99m hexamethyl propylene amine oxine (99mTc-HMPAO) leucocytes using a numerical grading system (scores 0-3). A 4-h series of scintigrams showed a significant correlation with both histological and macroscopical assessment of disease activity (rho = 0.850, P less than 0.001 and rho = 0.773, P less than 0.001, respectively). Sensitivity, specificity and accuracy of scintigraphy in detecting active inflammatory segments were 85%, 92% and 89%, respectively. A normal scintigram did not completely exclude mild inflammatory activity, especially in the rectosigmoid area. 99mTc-HMPAO leucocytes offer an accurate and non-invasive alternative for the assessment of disease activity in ulcerative colitis and Crohn's disease.

MeSH terms

  • Adult
  • Aged
  • Colitis, Ulcerative / diagnostic imaging
  • Colitis, Ulcerative / epidemiology
  • Colitis, Ulcerative / pathology
  • Crohn Disease / diagnostic imaging
  • Crohn Disease / epidemiology
  • Crohn Disease / pathology
  • Female
  • Finland / epidemiology
  • Humans
  • Inflammatory Bowel Diseases / diagnostic imaging*
  • Inflammatory Bowel Diseases / epidemiology
  • Inflammatory Bowel Diseases / pathology
  • Leukocytes*
  • Male
  • Middle Aged
  • Organotechnetium Compounds*
  • Oximes*
  • Prospective Studies
  • Radionuclide Imaging
  • Technetium Tc 99m Exametazime

Substances

  • Organotechnetium Compounds
  • Oximes
  • Technetium Tc 99m Exametazime